Original Article Nuclear Division Cycle 80 Complex Is Associated with Malignancy and Predicts Poor Survival of Hepatocellular Carcinoma

Original Article Nuclear Division Cycle 80 Complex Is Associated with Malignancy and Predicts Poor Survival of Hepatocellular Carcinoma

Int J Clin Exp Pathol 2019;12(4):1233-1247 www.ijcep.com /ISSN:1936-2625/IJCEP0086788 Original Article Nuclear division cycle 80 complex is associated with malignancy and predicts poor survival of hepatocellular carcinoma Xiaowei Chen*, Wenwen Li*, Lushan Xiao, Li Liu Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, P. R. China. *Equal contributors. Received October 15, 2018; Accepted October 26, 2018; Epub April 1, 2019; Published April 15, 2019 Abstract: The NDC80 (nuclear division cycle 80) complex takes part in chromosome segregation by forming an outer kinetochore and providing a platform for the interaction between chromosomes and microtubules, thus impacting the progression of mitosis and the cell cycle. The clinical significance of its components, NDC80, nuf2, spc24, and spc25, were widely explored in various malignancies respectively, yet seldom were they studied from the perspec- tive of a complex. This paper explores the clinical importance of the NDC80 kinetochore complex components in terms of their expression level, prognostic value, and therapeutic potential in HCC (hepatocellular carcinoma) patients. With the data from several paired HCC samples from Nanfang Hospital, HCC patients from the TCGA da- tabase and other cases from GSE89377, we analyzed the expression levels of the NDC80 complex components, NDC80/nuf2/spc24/spc25, along with the survival data as well as other clinical features using statistical methods and GSEA. The study found that a high expression of NDC80 complex predicts poor survival, and these components have the potential to be used as therapeutic targets. Keywords: Hepatocellular carcinoma, nuclear division cycle 80 complex, overexpression, prognosis Introduction interfering screen also revealed the therapeutic potential of targeting NDC80 and nuf2 [10, 11]. The NDC80 kinetochore complex forms the The tumorigenicity of spc24 has been con- outer kinetochore to interact with microtubules, firmed, and the knockdown of spc24 represses therefore assuring proper chromosome segre- tumor growth and invasion but increased cell gation during the progression of the cell cycle apoptosis in anaplastic thyroid cancer [12]. [1]. The complex has four components: NDC80 Apart from malignancies, NDC80 has also been (Hec1, Highly Expressed in Cancer Protein), reported to be involved in autoimmune diseas- nuf2 (CDCA1), spc24 (Spindle Pole Body es like type 1 diabetes [13], and the diagnostic Component 24 Homolog) and spc25 (Spindle importance of spc25 has been shown in Pole Body Component 25 Homolog). Aberrant Alzheimer’s disease [14]. Thus, efforts explor- expression or additional configuration [2] of ing the functions and mechanisms of NDC80’s these components got the attention of scholars components are of great significance. due to the importance of the cell cycle in cell proliferation. It is well-documented that mis- Hepatocellular carcinoma (HCC) ranks as the regulated NDC80, nuf2, spc24, and spc25 con- fifth most common cancer [15] and contributes tribute to the unchained proliferation, invasion, to more than 500,000 cancer-related deaths and restrained apoptosis [3-6], their expres- worldwide every year [16]. Because of the can- sion thus linking extensively to poor prognosis cer’s highly proliferative and invasive features, in various tumors [7, 8]. Moreover, siRNA target- most HCC patients merely receive an unsatis- ing of the four components prohibited cell pro- factory curative effect from their hepatecto- liferation and increased apoptosis in gastric mies, TACE or other therapies [17, 18]. Several and colorectal cancers [9, 10], and an RNA studies have reported the significance of the Upregulation of NDC80 complex in HCC NDC80 kinetochore complex in the develop- NDC80 group and the rest as the high NDC80 ment and regression of HCC [3, 19-21], while group, with 177 cases in each group. further studies are still required for comprehen- sive understanding of their clinical relevance The GSE89377 dataset (https://www.ncbi.nlm. and therapeutic value. NDC80 components nih.gov/geo/geo2r/?acc=GSE89377) was do- assemble the outer kinetochore, which medi- wnloaded from the GEO website, and the co- ates the interaction between chromosomes hort contains 108 cases in total, including 13 and microtubules. Thus, the four components, healthy people, 9 patients with low-grade NDC80, nuf2, spc24, and spc25 should be a chronic hepatitis, 12 with high-grade chronic structural and functional macrocosm, yet they hepatitis, 12 with cirrhosis, 11 with low-graded seldom are analyzed collectively [22]. dysplastic nodules, 11 with high-graded dys- plastic nodules, 5 with early HCC, 9 with Stage Hence, we aimed to elucidate the clinical mean- I HCC, 12 with Stage II HCC and 14 with Stage ing of the expression of the NDC80 complex III HCC. The analysis of the data was performed and discuss its molecular mechanisms to offer based on the platform GPL6947 (https://www. a strategy for exploiting their possible thera- ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL- peutic implications. 6947). Material and methods The gene set enrichment analysis (GSEA) Patients and tissues The gene set enrichment analysis (GSEA) was used to screen gene sets or pathways that are The experimental design of the current study associated with the expression of the interest- has been reviewed and approved by the Ethics ed genes, NDC80, nuf2, spc24, and spc25 in Committee of Nangfang Hospital, Southern the TCGA dataset. Taking NDC80 as example, Medical University (Guangzhou, China). Patients the patients were divided into 4 groups with the enrolled in the study did not receive any anti- quantiles of the expression levels of NDC80 cancer treatments before surgery, and the and the top and bottom quarter cases were specimens were collected between January included into the GSEA input as the groups and December 2015. Informed consents were NDC80_high and NDC80_low. The enrichment provided by all patients eligible for the collec- results were generated by GSEA software tion of HCC and adjacent non-tumor liver through analysis, annotation and interpreta- specimens. tion. The gene sets with the most members showing a positive relation to the NDC80 Data source expression were termed associated with NDC80. The significance threshold was set Data from the 354 HCC patients were obtained at P < 0.05. from the TCGA dataset to compare their differ- ent expressions of NDC80, nuf2, spc24, and RNA extraction, cDNA synthesis and RT-qPCR spc25. The data comprise follow-up informa- analysis tion and genome-wide expression profiles of these patients for phenotype investigation. The total RNA of HCC and non-tumor adjacent Patients with available data on their NDC80/ liver tissues was extracted using the TRIzol® nuf2/spc24/spc25 expression and clinical reagent (Invitrogen; Thermo Fisher Scientific, information were included in the current study. Inc., Waltham, MA, USA), according to the man- The expression profiles of the tumor tissues ufacturer’s protocol. cDNA synthesis was per- from 354 patients and 50 adjacent liver tis- formed using the PrimeScripTM RT Reagent Kit sues were obtained. Taking NDC80 as an exam- strictly according to the protocol offered by ple, the 354 patients were divided into two Takara Biotechnology Co., Ltd., Dalian, China. groups, the NDC80 high group and the NDC80 First, genomic DNA were removed using the low group, according to NDC80 expression level DNA Eraser and the corresponding buffer and with the median expression level of NDC80 as minimal volume of the sample were subjected the cutoff. Patients with NDC80 expression to a NanoDrop® spectrophotometer (Thermo below the median were classified as the low Fisher Scientific, Inc.) to measure the quality 1234 Int J Clin Exp Pathol 2019;12(4):1233-1247 Upregulation of NDC80 complex in HCC and concentration of total RNA. The RNA was Results then transcribed into cDNA using a Primer mix RT kit (Takara Biotechnology Co., Ltd.) in a 20 µl Components of NDC80 complex are overex- reaction volume with 1 µg RNA. Subsequently, pressed in HCC amplification reactions were performed using a SYBR Green PCR kit from Takara Biotechnology The NDC80 complex is composed of four com- Co., Ltd., using the following primers: NDC80 ponents: NDC80, nuf2, spc24 and spc25. In sense, 5’-ATCAAGG ACCCGAGACCACT-3’, and order to determine the expression levels of anti-sense, 5’-GTGCAAAAGGATACCCAAGGT-3’; these components in HCC, we analyzed the nuf2 sense, 5’-GAAGGAAGCCTGCAGACAGA-3’, data of the HCC patients obtained from The and anti-sense, 5’-GCAAGACTTCAGGCTTTGG- Cancer Genome Atlas (TCGA) database and A-3’; spc24 sense, 5’-CTGCGAGAGATCCTCAC- found that all of them were notably overex- CAT-3’, and anti-sense, 5’-TTGTGACTGTCGTG- pressed in HCC as compared with non-tumor TCCTCG-3’; spc25 sense, 5’-TACGGACACCTC- hepatic tissues (P < 0.001, Figure 1A). Also, we CTGTCAGA-3’, and anti-sense, 5’-GGGCACTAT- detected the expression of these components CTGACACTTCAT-3’; GAPDH sense, 5’-GACAGT- in HCC and in the adjacent normal liver tissues CAGCCGCATCTTCT-3’, and anti-sense, 5’-AA- and found notable overexpressions of NDC80 ATGAGCCCCAGCCTTCTC. GAPDH was amplified and nuf2 in the tumor lesions while spc24 and as an internal control. Gene-specific amplifica- spc25 showed little difference between the tion was performed using a LightCycler® 480 tumor and non-tumor tissues, probably due to Instrument II (Roche Diagnostics, Basel, the sample size of the detection

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    15 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us